<p>COPD, chronic obstructive pulmonary disease; EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase.</p><p>Multivariate analysis of patient characteristics associated with EGFR and ALK mutation statuses.</p
<p>Clinical and disease characteristics of patients with EGFR gene TKI-sensitive mutations and patie...
<p>Clinical characteristics of <i>EGFR</i> mutation (M) and wildtype (wt) cohorts.</p
Although it is known that smoking is one of the main factors causing chronic inflammation and that c...
<p>Univariate and multivariate analysis of predictors of <i>EGFR</i> mutation.</p
<p>Logistic regression analysis of patient characteristics associated with COPD, <i>KRAS</i> and <i>...
<p>EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; EML4, echinoderm microtu...
<p>Multivariate analysis of progression-free survival and overall survival in patients with the EGFR...
<p>Clinicopathological characteristics and disease recurrence in patients with stage I <i>EGFR</i>-m...
<p>Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...
a<p><i>P</i><0.05.</p><p>ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor.</p
<div><p>Lung cancer and chronic obstructive pulmonary disease (COPD) are two major lung diseases. Ep...
<p>Association between EGFR mutations and the presence of COPD in non-smokers (n = 199).</p
<p>Impact of <i>EGFR</i> activating mutation on survival of non-small-cell lung cancer patients by f...
<p>*Light smokers referred to patients who had smoked less than 100 cigarettes in their lifetime.</p...
Introduction: Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutationa...
<p>Clinical and disease characteristics of patients with EGFR gene TKI-sensitive mutations and patie...
<p>Clinical characteristics of <i>EGFR</i> mutation (M) and wildtype (wt) cohorts.</p
Although it is known that smoking is one of the main factors causing chronic inflammation and that c...
<p>Univariate and multivariate analysis of predictors of <i>EGFR</i> mutation.</p
<p>Logistic regression analysis of patient characteristics associated with COPD, <i>KRAS</i> and <i>...
<p>EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; EML4, echinoderm microtu...
<p>Multivariate analysis of progression-free survival and overall survival in patients with the EGFR...
<p>Clinicopathological characteristics and disease recurrence in patients with stage I <i>EGFR</i>-m...
<p>Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...
a<p><i>P</i><0.05.</p><p>ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor.</p
<div><p>Lung cancer and chronic obstructive pulmonary disease (COPD) are two major lung diseases. Ep...
<p>Association between EGFR mutations and the presence of COPD in non-smokers (n = 199).</p
<p>Impact of <i>EGFR</i> activating mutation on survival of non-small-cell lung cancer patients by f...
<p>*Light smokers referred to patients who had smoked less than 100 cigarettes in their lifetime.</p...
Introduction: Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutationa...
<p>Clinical and disease characteristics of patients with EGFR gene TKI-sensitive mutations and patie...
<p>Clinical characteristics of <i>EGFR</i> mutation (M) and wildtype (wt) cohorts.</p
Although it is known that smoking is one of the main factors causing chronic inflammation and that c...